바로가기메뉴

본문 바로가기 주메뉴 바로가기

Tuberculosis & Respiratory Diseases

Article Contents

Prev Next
e-Submission

Vol.57 No.3
Citation Share

Association between RASSF1A Methylation and Clinicopathological Factors in Patients with Squamous Cell Carcinoma of Lung

Tuberculosis & Respiratory Diseases / Tuberculosis & Respiratory Diseases,
2004, v.57 no.3, pp.265-272









& (2004). Association between RASSF1A Methylation and Clinicopathological Factors in Patients with Squamous Cell Carcinoma of Lung. Tuberculosis & Respiratory Diseases, 57(3), 265-272.
  • Downloaded
  • Viewed
PDF Download

Abstract

Background:RASSF1A, which is one of tumor suppressor genes, is frequently inactivated by hypermethylation of the promoter region in a variety of human cancers, including lung cancer. This study was performed to investigate the association between RASSF1A methylation and the clinicopathological factors in patients with squamous cell carcinoma of the lung. Methods:Eighty-one samples from the patients with squamous cell carcinoma of lung were examined. The promoter methyation of RASSF1A was analyzed by methylation specific PCR and sequencing. Statistical analysis was made to examine the association between RASSF1A methylation and the clinicopathological parameters. Results:RASSF1A methylation was observed in 37.0 % (30 of 81) of the patients with squamous cell carcinoma of the lung. RASSF1A methylation was found to be associated with cellular differentiation(p=0.0097) and the overall survival(p=0.0635). However, there was no association between RASSF1A methylation and the other clinicopathological parameters, such as the pathological TNM stage, the recurrence rate, lymph node invasion and the amount of cigarettes smoked. Conclusion:RASSF1A methylation might be associated with a poor prognosis in patients with squamous carcinoma of the lung. A larger scale study is needed.(Tuberc Respir Dis 2004; 57:265-272)

keywords
Methylation, Squamous cell carcinoma, Tumor suppressor gene.편평상피폐암에서 암억제유전자 RASSF1A의 메틸화와 임상 및 병리소견과의 연관성성균관대학교 의과대학 삼성생명과학연구소 임상의학센터 암연구센터1, 호흡기내과2, 흉부외과3, 한국과학기술원 생명과학과4최내윤1, 이혜숙1, 송인승1, 임유성1, 손대순1, 임대식4, 최용수3, 김진국3, 김호중2Association between RASSF1A

Reference

1.

(2001) Cancer burden in the year 2000. The global picture,

2.

(1999) Histological typing of lung and pleural tumours, Springer

3.

(1999) Molecular detection of early lung cancer,

4.

(1996) United States lung carcinoma incidence trends: declining for most histologic types among males, increasing among females,

5.

(2000) High resolution chromosome 3p allelotyping of human lung cancer and preneoplasic/preinvasive bronchial epithelium reveals multiple, discontinuous sites of 3p allele loss and three regions of frequent breakpoints,

6.

(2002) Molecular pathogenesis of lung cancer,

7.

(1999) How many tumor suppressor genes are involved in human lung carcinogenesis?,

8.

(1997) Deletions of the short arm of chromosome 3 in solid tumors and the search for suppressor genes,

9.

(2000) The 630-kb lung cancer homozygous deletion region on human chromosome 3p21.3: identification and evaluation of the resident candidate tumor suppressor genes. The International Lung Cancer Chromosome 3p21.3 Tumor Suppressor Gene Consortium,

10.

(1998) Cloning of a breast cancer homozygous deletion junction narrows the region of search for a 3p21.3 tumor suppressor gene,

11.

(2000) Bates S, Pfeifer GP. Epigenetic inactivation of a RAS association domain family protein from the lung tumor suppressor locus 3p21.3,

12.

(2001) Epigenetic inactivation of RASSF1A in lung and breast cancers and malignant phenotype suppression,

13.

(2003) Hypermethylation of the tumor suppressor gene RASSFIA and frequent concomitant loss of heterozygosity at 3p21 in cervical cancers,

14.

(2002) Promoter hypermethylation of tumor- related genes in gastric intestinal metaplasia of patients with and without gastric cancer,

15.

(2002) Promoter hypermethylation of multiple genes in nasopharyngeal carcinoma,

16.

(2001) Methylation associated inactivation of RASSF1A from region 3p21.3 in lung, breast and ovarian tumors,

17.

(2001) The CpG island of the novel tumor suppressor gene RASSF1A is intensely methylated in primary small cell lung carcinomas,

18.

(2002) Clinicopathological significance of epigenetic inactivation of RASSF1A at 3p21.3 in stage I lung adenocarcinoma,

19.

(2003) Smoke exposure, histologic type and geography-related differences in the methylation profiles of non-small cell lung cancer,

20.

(2003) Aberrant methylation of multiple genes in the upper aerodigestive tract epithelium of heavy smokers,

21.

(2004) The tumour suppressor RASSF1A regulates mitosis by inhibiting the APC-Cdc20 complex.,

22.

(1996) Nelkin BD Baylin SB. Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands,

23.

(2003) RASSF1A gene inactivation in non-small cell lung cancer and its clinical implication,

24.

(2002) Identification of a novel Ras-regulated proapoptotic pathway,

25.

(2002) The putative tumor suppressor RASSF1A homodimerizes and heterodimerizes with the Ras-GTP binding protein Nore1,

Tuberculosis & Respiratory Diseases

e-Submission OA Policy